These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2178315)

  • 1. Differential regulation of the activation of human eosinophils, macrophages, and neutrophils: effect of the allergic mediator release inhibitor CI-949.
    Wright CD; Devall LJ; Aker DO; Thueson DO; Conroy MC
    Agents Actions; 1990 Aug; 31(1-2):11-5. PubMed ID: 2178315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of human eosinophil, macrophage, and neutrophil functions by the allergic mediator release inhibitor CI-959.
    Wright CD; Devall LJ; Aker KA; Thueson DO; Conroy MC
    Agents Actions; 1992 May; 36(1-2):11-6. PubMed ID: 1329446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-949.
    Wright CD; Stewart SF; Kuipers PJ; Hoffman MD; Thueson DO; Conroy MC
    J Leukoc Biol; 1991 Jan; 49(1):58-64. PubMed ID: 1845811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective regulation of human neutrophil functions by the cell activation inhibitor CI-959.
    Wright CD; Stewart SF; Kuipers PJ; Hoffman MD; Devall LJ; Kennedy JA; Ferin MA; Thueson DO; Conroy MC
    J Leukoc Biol; 1994 Apr; 55(4):443-51. PubMed ID: 8145014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-922: differential inhibition of responses to a variety of stimuli.
    Wright CD; Hoffman MD; Thueson DO; Conroy MC
    J Leukoc Biol; 1987 Jul; 42(1):30-5. PubMed ID: 2439626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-949: mechanism of inhibitory activity.
    Wright CD; Kuipers PJ; Hoffman MD; Thueson DO; Conroy MC
    Biochem Biophys Res Commun; 1990 Mar; 167(2):828-34. PubMed ID: 2322255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils.
    Mabuchi K; Sugiura T; Ojima-Uchiyama A; Masuzawa Y; Waku K
    Biochem Int; 1992 May; 26(6):1105-13. PubMed ID: 1321621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential superoxide anion generation by equine eosinophils and neutrophils.
    Foster AP; Cunningham FM
    Vet Immunol Immunopathol; 1997 Nov; 59(3-4):225-37. PubMed ID: 9477474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine chloramine inhibits functional responses of human eosinophils in vitro.
    Martinez-Losa M; Cortijo J; Piqueras L; Sanz MJ; Morcillo EJ
    Clin Exp Allergy; 2009 Apr; 39(4):537-46. PubMed ID: 19222497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein kinase C inhibitors H-7 and H-9 fail to inhibit human neutrophil activation.
    Wright CD; Hoffman MD
    Biochem Biophys Res Commun; 1986 Mar; 135(3):749-55. PubMed ID: 3008744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of superoxide generation and luminol-dependent chemiluminescence with eosinophils and neutrophils from normal individuals.
    Shult PA; Graziano FM; Wallow IH; Busse WW
    J Lab Clin Med; 1985 Dec; 106(6):638-45. PubMed ID: 2999272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.
    Moy JN; Gleich GJ; Thomas LL
    J Immunol; 1990 Oct; 145(8):2626-32. PubMed ID: 2170521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release.
    Ogawa H; Kunkel SL; Fantone JC; Ward PA
    Am J Pathol; 1981 Nov; 105(2):149-55. PubMed ID: 7294162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils.
    Sedgwick JB; Vrtis RF; Gourley MF; Busse WW
    J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):876-83. PubMed ID: 2836491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation.
    Banner KH; Moriggi E; Da Ros B; Schioppacassi G; Semeraro C; Page CP
    Br J Pharmacol; 1996 Nov; 119(6):1255-61. PubMed ID: 8937731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory burst of normal human eosinophils.
    Petreccia DC; Nauseef WM; Clark RA
    J Leukoc Biol; 1987 Apr; 41(4):283-8. PubMed ID: 3033106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of degranulation from human eosinophils by platelet-activating factor.
    Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
    J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the human polymorphonuclear leukocyte inflammatory response by inhibitors of arachidonic acid metabolism.
    Yocum DE; Hempel S; Busse WW
    J Immunopharmacol; 1984; 6(4):237-55. PubMed ID: 6098611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of lysosomal enzyme beta-glucuronidase from isolated human eosinophils.
    Marshall T; Shult P; Busse WW
    J Allergy Clin Immunol; 1988 Oct; 82(4):550-5. PubMed ID: 3170999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.